BMY
BRISTOL-MYER SQB
Health Care·Pharmaceuticals·UNITED STATES
$56.48
MCap $115.3B
as of 2026-06-09
Total
C1w
Fund
C1w
Quant
B1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-10
MIDOS SI
+0.35
Sentiment 23.0%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$56.48
Adaptive Mean
$55.91
+0.57 vs mean
Adaptive σ
0.83
MIDOS BB
$54.25 – $57.56
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
+0.16
ROE
38.8%
Z +0.90
Rev Gr
2.6%
Z -0.28
EPS Gr
30.6%
Z +0.04
OPM Gr
-3.6%
Z -0.38
FCF Yld
10.3%
Z +0.67
EPS Surp
12.6%
Z +0.03
EPS 3mo Δ
-3.2%
Z +0.15
Fwd P/E
9.16
Z —
PEGY
0.02
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-10
Q3M
-5.80
Q6M
3.34
Q12M
2.79
MA 30/100
0.984
Bearish (MA30 < MA100)
α (Jensen)
-0.2985
β (12M)
0.32
σ (12M)
0.270
Divergence — Fundamentals vs Momentum
Z Percentile
76%
Q Percentile
67%
Divergence
+8.1
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
11.5
RS Pctl
66%
RS Decile
D7
Persistence
1w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.